Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

(33:29)

How does acute myeloid leukemia (AML) relate to MDS?

(2:25)

MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS Patients

(50:26)

From MDS to AML: What Every Patient Needs to Know 11/28/17

(34:15)

What’s the connection between myelodysplastic syndrome (MDS) and AML-MRC?

(1:27)

From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17

(1:40:23)

Myelodysplastic Syndrome (MDS) - a precursor to Acute Myeloid Leukemia (AML) ?! - Hematology Series

(13:47)

Expanding treatment options for AML to patients with MDS

(1:13)

The Role of BMT in Treatment-Related MDS and AML

(6:50)

Managing the progression of MDS to AML

(2:38)

Expert Explains the Greatest Challenge in Treating Patients With MDS and AML

(1:31)

Distinguishing between AML and MDS and addressing overlap between these diseases

(1:20)

MDS, inflammation and AML

(1:32)

Innovations in MDS and AML treatment

(1:36)

How do you distinguish between a diagnosis of MDS and AML? #AML

(48)

MDS/AML Overlap and Novel Therapies with Dr. Naval Daver

(9:29)

Understanding Higher Risk MDS and Transtion to AML

(1:13:29)

Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML

(1:56)

MDS/AML germline predisposition syndromes in pediatric patients: GATA2 and SAMD9/9L

(2:47)

Hurdles to CAR-T therapy for MDS \u0026 AML: T-cell fitness \u0026 lack of a uniform target antigen

(1:16)